- Home
- CDTX vs COTY Comparison
CDTX vs COTY Comparison
Compare CDTX & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- COTY
- Stock Information
- Founded
- CDTX 2012
- COTY 1904
- Country
- CDTX United States
- COTY United States
- Employees
- CDTX N/A
- COTY N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- COTY Package Goods/Cosmetics
- Sector
- CDTX Health Care
- COTY Consumer Discretionary
- Exchange
- CDTX Nasdaq
- COTY Nasdaq
- Market Cap
- CDTX 2.8B
- COTY 2.9B
- IPO Year
- CDTX 2015
- COTY 2013
- Fundamental
- Price
- CDTX $219.75
- COTY $3.15
- Analyst Decision
- CDTX Buy
- COTY Hold
- Analyst Count
- CDTX 13
- COTY 16
- Target Price
- CDTX $119.44
- COTY $5.60
- AVG Volume (30 Days)
- CDTX 2.2M
- COTY 6.4M
- Earning Date
- CDTX 11-06-2025
- COTY 11-05-2025
- Dividend Yield
- CDTX N/A
- COTY N/A
- EPS Growth
- CDTX N/A
- COTY N/A
- EPS
- CDTX N/A
- COTY N/A
- Revenue
- CDTX N/A
- COTY $5,798,600,000.00
- Revenue This Year
- CDTX N/A
- COTY $1.27
- Revenue Next Year
- CDTX N/A
- COTY $2.55
- P/E Ratio
- CDTX N/A
- COTY N/A
- Revenue Growth
- CDTX N/A
- COTY N/A
- 52 Week Low
- CDTX $15.02
- COTY $3.12
- 52 Week High
- CDTX $220.32
- COTY $8.04
- Technical
- Relative Strength Index (RSI)
- CDTX 89.35
- COTY 25.11
- Support Level
- CDTX $102.46
- COTY $3.53
- Resistance Level
- CDTX $218.85
- COTY $4.16
- Average True Range (ATR)
- CDTX 4.30
- COTY 0.16
- MACD
- CDTX 12.80
- COTY -0.05
- Stochastic Oscillator
- CDTX 99.47
- COTY 0.00
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About COTY Coty Inc.
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake as of June 2025.